Nasdaq · CIK 0001533998
DRIO DarioHealth Corp.
Insider trading from SEC Form 4. Last filing 15 d ago. Close $5.80 on Oct 9, 2026, +7% from the 52-week low and -64% from the high.
DarioHealth Corp. (DRIO) has 22 SEC Form 4 filings on file from 11 insiders, the latest filed on Sep 28, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at DRIO. The newest: Steven Charles Nelson (President and CCO) bought $21k of stock on Aug 27, 2025, filed Aug 27, 2025, scored 38 (weak).
DRIO closed at $5.80 on Oct 9, 2026, 7% above its 52-week low and 64% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at DarioHealth Corp., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Steven Charles Nelson President and CCO buy | $21k 40,000 shares | +73% | +12% from low-69% from high | |
| 18Weak | Steven Charles Nelson Chief Commercial Officer buy | $4,546 5,000 shares | +10% | - |
Transactions
Every row filed, 30 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Hila Karah director | AGrant or award Common Stock | +28,000 | $0.00 | $0 | 58,965 | 15 d ago |
| Sep 24, 2026 | Dennis Matheis director | AGrant or award Common Stock | +44,000 | $0.00 | $0 | 87,026 | 15 d ago |
| Sep 24, 2026 | Chen Franco-Yehuda Chief Financial Officer | AGrant or award Common Stock | +95,000 | $0.00 | $0 | 125,000 | 15 d ago |
| Sep 24, 2026 | Dennis M McGrath director | AGrant or award Common Stock | +61,000 | $0.00 | $0 | 88,737 | 15 d ago |
| Sep 24, 2026 | John R Palumbo director | AGrant or award Common stock | +62,000 | $0.00 | $0 | 66,500 | 15 d ago |
| Sep 18, 2025 | Adam K Stern director | CConversion Common Stockindirect: By AKS Family Partners L.P. | +11,760 | $40.40 | $475k | 17,906 | 15 d ago |
| Aug 12, 2024 | Yoav Shaked director | CConversion Common Stock | +772 | $19.10 | $15k | 33,582 | 15 d ago |
| Aug 12, 2024 | Erez Raphael Chief Executive Officer | CConversion Common Stock | +579 | $19.10 | $11k | 157,432 | 15 d ago |
| Sep 24, 2026 | Yoav Shaked director | AGrant or award Common Stock | +54,000 | $0.00 | $0 | 87,582 | 15 d ago |
| Sep 18, 2025 | Adam K Stern director | CConversion Common Stockindirect: By AKS Family Partners L.P. | +8,435 | $16.60 | $140k | 26,341 | 15 d ago |
| Sep 24, 2026 | Erez Raphael Chief Executive Officer | AGrant or award Common Stock | +297,000 | $0.00 | $0 | 454,432 | 15 d ago |
| Sep 24, 2026 | Adam K Stern director | AGrant or award Common Stock | +28,000 | $0.00 | $0 | 57,717 | 15 d ago |
| Aug 12, 2024 | Yoav Shaked director | CConversion Series B-2 Preferred Stockderivative | -40 | $1,000.00 | $40k | 0 | 15 d ago |
| Aug 12, 2024 | Erez Raphael Chief Executive Officer | CConversion Series B-2 Preferred Stockderivative | -30 | $1,000.00 | $30k | 0 | 15 d ago |
| Sep 18, 2025 | Adam K Stern director | CConversion Series C Preferred Stockderivativeindirect: By AKS Family Partners L.P. | -250 | $1,000.00 | $250k | 0 | 15 d ago |
| Sep 18, 2025 | Adam K Stern director | CConversion Series D-2 Preferred Stockderivativeindirect: By AKS Family Partners L.P. | -100 | $1,000.00 | $100k | 0 | 15 d ago |
| Sep 11, 2025 | Dennis M McGrath director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 27,737 | Sep 15, 2025 |
| Sep 11, 2025 | Chen Franco-Yehuda Chief Financial Officer | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 30,000 | Sep 15, 2025 |
| Sep 11, 2025 | Erez Raphael Chief Executive Officer | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 156,853 | Sep 15, 2025 |
| Sep 11, 2025 | Yoav Shaked director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 32,810 | Sep 15, 2025 |
| Sep 11, 2025 | Lawrence B. Leisure director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 20,000 | Sep 15, 2025 |
| Sep 11, 2025 | Adam K Stern director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 29,717 | Sep 15, 2025 |
| Sep 11, 2025 | Steven Charles Nelson President and CCO | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 34,750 | Sep 15, 2025 |
| Sep 11, 2025 | Hila Karah director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 30,965 | Sep 15, 2025 |
| Sep 11, 2025 | Dennis Matheis director | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 27,631 | Sep 15, 2025 |
| Aug 27, 2025 | Steven Charles Nelson President and CCO | POpen-market purchase Common Stock | +40,000 | $0.53 | $21k | 95,000 | Aug 27, 2025 |
| May 15, 2025 | Chen Franco-Yehuda Chief Financial Officer | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 500,000 | May 15, 2025 |
| Feb 24, 2025 | Jon H. Kaplan director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 111,574 | Feb 25, 2025 |
| Jan 7, 2025 | Adam K Stern director | POpen-market purchase Series D-2 Preferred Stockderivativeindirect: AKS Family Partners L.P. | +100 | $1,000.00 | $100k | 0 | Jan 10, 2025 |
| Nov 12, 2024 | Steven Charles Nelson Chief Commercial Officer | POpen-market purchase Common Stock | +5,000 | $0.91 | $4,546 | 55,000 | Nov 14, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Chen Franco-YehudaChief Financial Officer
- Jon H. Kaplandirector
- Hila Karahdirector
- Lawrence B. Leisuredirector
- Dennis M McGrathdirector, cfo, president, officer
- Dennis Matheisdirector
- Steven Charles NelsonPresident and CCO
- John R Palumbodirector
- Erez RaphaelChief Executive Officer
- Adam K Sterndirector
- Yoav Shakeddirector
Questions about DRIO
Answered from the filings on this page, as of the latest one.
Are insiders buying DRIO?
No. In the last 90 days no insider at DarioHealth Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade DRIO on the open market?
Steven Charles Nelson (President and CCO) bought $21k of DRIO on Aug 27, 2025 and filed the Form 4 on Aug 27, 2025. InsiderTell scored 38 (weak).
How many insiders file Form 4 at DarioHealth Corp.?
11 people have filed a Form 4 at DarioHealth Corp., among them Chen Franco-Yehuda (Chief Financial Officer), Jon H. Kaplan (director), Hila Karah (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.